• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: Role of complement activation in kidney diseases.

作者信息

Oda Takashi, Sawai Toshihiro

机构信息

Department of Nephrology and Blood Purification, Kidney Disease Center, Tokyo Medical University Hachioji Medical Center, Hachioji, Japan.

Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan.

出版信息

Front Med (Lausanne). 2023 Oct 19;10:1297938. doi: 10.3389/fmed.2023.1297938. eCollection 2023.

DOI:10.3389/fmed.2023.1297938
PMID:37928465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10621785/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f28/10621785/507c87ecc4f3/fmed-10-1297938-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f28/10621785/507c87ecc4f3/fmed-10-1297938-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f28/10621785/507c87ecc4f3/fmed-10-1297938-g0001.jpg

相似文献

1
Editorial: Role of complement activation in kidney diseases.社论：补体激活在肾脏疾病中的作用
Front Med (Lausanne). 2023 Oct 19;10:1297938. doi: 10.3389/fmed.2023.1297938. eCollection 2023.
2
Role of complement activation in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.补体激活在抗中性粒细胞胞浆抗体相关肾小球肾炎中的作用。
Front Med (Lausanne). 2022 Dec 2;9:1031445. doi: 10.3389/fmed.2022.1031445. eCollection 2022.
3
Alternative complement pathway hemolytic assays reveal incomplete complement blockade in patients treated with eculizumab.替代补体途径溶血试验显示，接受依库珠单抗治疗的患者存在补体阻断不完全的情况。
Clin Immunol. 2017 Oct;183:1-7. doi: 10.1016/j.clim.2017.06.007. Epub 2017 Jun 21.
4
Discontinuation of dialysis with eculizumab therapy in a pediatric patient with dense deposit disease.在一名患有致密沉积物病的儿科患者中使用依库珠单抗治疗后停止透析
Pediatr Nephrol. 2016 Apr;31(4):683-7. doi: 10.1007/s00467-015-3306-0. Epub 2016 Jan 13.
5
Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.超生理水平的C1抑制剂对补体经典途径、凝集素途径和替代途径的影响。
Mol Immunol. 2007 Mar;44(8):1819-26. doi: 10.1016/j.molimm.2006.10.003. Epub 2006 Nov 13.
6
Successful treatment with avacopan (CCX168) in a pediatric patient with C3 glomerulonephritis.成功使用 avacopan（CCX168）治疗儿童 C3 肾小球肾炎患者。
Pediatr Nephrol. 2023 Dec;38(12):4197-4201. doi: 10.1007/s00467-023-06035-4. Epub 2023 Jun 12.
7
How the Availability of Anti-C5a Agents Could Change the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.抗C5a制剂的可用性如何改变抗中性粒细胞胞浆抗体相关血管炎的治疗
Kidney Blood Press Res. 2022;47(8):506-513. doi: 10.1159/000525357. Epub 2022 Jun 3.
8
Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders.补体介导的肾脏疾病中补体激活生物标志物及依库珠单抗的监测
Clin Exp Immunol. 2017 Feb;187(2):304-315. doi: 10.1111/cei.12890. Epub 2016 Nov 25.
9
Complementary Roles of the Classical and Lectin Complement Pathways in the Defense against .经典补体途径和凝集素补体途径在抵御……中的互补作用
Front Immunol. 2016 Nov 3;7:473. doi: 10.3389/fimmu.2016.00473. eCollection 2016.
10
Complement activation and effect of eculizumab in scleroderma renal crisis.补体激活及依库珠单抗在硬皮病肾危象中的作用
Medicine (Baltimore). 2016 Jul;95(30):e4459. doi: 10.1097/MD.0000000000004459.

本文引用的文献

1
Circulating immune-complexes and complement activation through the classical pathway in myeloperoxidase-ANCA-associated glomerulonephritis.髓过氧化物酶-抗中性粒细胞胞质抗体相关性肾小球肾炎中通过经典途径形成的循环免疫复合物和补体激活。
Ren Fail. 2022 Dec;44(1):714-723. doi: 10.1080/0886022X.2022.2068445.
2
Avacopan for the Treatment of ANCA-Associated Vasculitis.阿伐考潘治疗抗中性粒细胞胞浆抗体相关性血管炎。
N Engl J Med. 2021 Feb 18;384(7):599-609. doi: 10.1056/NEJMoa2023386.
3
A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy.
系统性红斑狼疮相关性血栓性微血管病中依库珠单抗作用的系统评价。
BMC Nephrol. 2020 Jun 30;21(1):245. doi: 10.1186/s12882-020-01888-5.
4
The role of complement in arterial hypertension and hypertensive end organ damage.补体在动脉高血压和高血压靶器官损害中的作用。
Br J Pharmacol. 2021 Jul;178(14):2849-2862. doi: 10.1111/bph.15171. Epub 2020 Aug 19.
5
Serum Mannose-Binding Lectin Levels Are Correlated with the Disease Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Single-Center Study.血清甘露糖结合凝集素水平与抗中性粒细胞胞质抗体相关性血管炎的疾病活动度相关：一项单中心研究。
Tohoku J Exp Med. 2020 Jun;251(2):117-123. doi: 10.1620/tjem.251.117.
6
Intrarenal Arterial Lesions Are Associated with Higher Blood Pressure, Reduced Renal Function and Poorer Renal Outcomes in Patients with IgA Nephropathy.肾内动脉病变与IgA肾病患者的高血压、肾功能下降及肾脏预后较差有关。
Kidney Blood Press Res. 2018;43(2):639-650. doi: 10.1159/000489290. Epub 2018 Apr 23.
7
The Complement System in Dialysis: A Forgotten Story?补体系统在透析中的作用：被遗忘的故事？
Front Immunol. 2018 Jan 25;9:71. doi: 10.3389/fimmu.2018.00071. eCollection 2018.
8
A pathogenic role of complement in arterial hypertension and hypertensive end organ damage.补体在动脉高血压和高血压性终末器官损伤中的致病作用。
Am J Physiol Heart Circ Physiol. 2017 Mar 1;312(3):H349-H354. doi: 10.1152/ajpheart.00759.2016. Epub 2016 Dec 16.
9
Complement in ANCA-associated glomerulonephritis.补体在抗中性粒细胞胞浆抗体相关性肾小球肾炎中的作用。
Nephrol Dial Transplant. 2017 Aug 1;32(8):1302-1313. doi: 10.1093/ndt/gfv288.
10
Expression of membrane complement regulators, CD46, CD55 and CD59, in mesothelial cells of patients on peritoneal dialysis therapy.腹膜透析治疗患者间皮细胞中膜补体调节蛋白CD46、CD55和CD59的表达
Mol Immunol. 2015 Jun;65(2):302-9. doi: 10.1016/j.molimm.2015.02.005. Epub 2015 Feb 25.